Form 4: National Healthcare Corp Director Adams Receives Stock Option Grant
SEC Form 4
Director Robert G. Adams of National Healthcare Corp received a stock option grant on May 8, 2025, according to a Form 4 filing with the SEC.
Summary
- Robert G. Adams, a director at National Healthcare Corp (NHC), filed a Form 4 with the SEC.
- The filing reports the grant of stock options to Adams on May 8, 2025.
- Adams received options to purchase 7,500 shares of NHC common stock at an exercise price of $94.66 per share.
- These options were granted pursuant to the 2020 Omnibus Equity Incentive Plan.
- The options become exercisable on May 8, 2026, and expire on May 7, 2030.
- Adams also directly owns options from previous grants in 2021, 2022, 2023 and 2024.
- Adams also indirectly owns 430,341 shares of common stock through a partnership and 9,079 shares through a trust.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing related to stock option grants, which is generally neutral in sentiment. It indicates continued alignment of the director with the company's performance.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the director.
Industry Context
Stock option grants are a common practice in the healthcare industry to incentivize and retain key personnel.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in publicly traded healthcare companies.
- The size of the grant is within the normal range for director-level compensation at companies of similar size and market capitalization.
Stakeholder Impact
- The stock option grant could potentially dilute existing shareholders if the options are exercised.
- The grant incentivizes the director to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/06/2022 | Date options from 2021 grant became exercisable |
| 05/05/2023 | Date options from 2022 grant became exercisable |
| 05/04/2024 | Date options from 2023 grant became exercisable |
| 05/08/2025 | Date of the current stock option grant and date options from 2024 grant became exercisable |
| 05/08/2026 | Date options from 2025 grant become exercisable |
| 05/05/2026 | Expiration date of options from 2021 grant |
| 05/04/2027 | Expiration date of options from 2022 grant |
| 05/03/2028 | Expiration date of options from 2023 grant |
| 05/08/2029 | Expiration date of options from 2024 grant |
| 05/07/2030 | Expiration date of options from 2025 grant |
Keywords
stock options, Form 4, National Healthcare Corp, NHC, Robert G. Adams, insider trading, equity incentive plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.